In this issue:
High-affinity CD16AV176 and risk of severe COVID-19
Analysis of therapeutic mRNA molecules
Reason for decline in protective antibodies after mRNA vaccines
One-year findings of hospitalised COVID-19 patients
NVX-CoV2601 versus NVX-CoV2373
Serology and immunogenicity of SARS-CoV-2
The pandemic and its impact on cognitive function
APP and improved clinical outcomes
Increasing COVID-19 vaccine uptake
Efficacy of NVX-CoV2373 protein subunit vaccine for adolescents
Please login below to download this issue (PDF)